Pharmacokinetics and pharmacodynamics of imatinib for optimal drug repurposing from cancer to COVID-19

INTRODUCTION: In the randomized double-blind placebo-controlled CounterCOVID study, oral imatinib treatment conferred a positive clinical outcome and a signal for reduced mortality in COVID-19 patients. High concentrations of alpha-1 acid glycoprotein (AAG) were observed in these patients and were a...

Descripción completa

Detalles Bibliográficos
Autores principales: Baalbaki, Nadia, Duijvelaar, Erik, Said, Medhat M., Schippers, Job, Bet, Pierre M., Twisk, Jos, Fritchley, Sarah, Longo, Cristina, Mahmoud, Kazien, Maitland-van der Zee, Anke H., Bogaard, Harm Jan, Swart, Eleonora L., Aman, Jurjan, Bartelink, Imke H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Authors. Published by Elsevier B.V. 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979628/
https://www.ncbi.nlm.nih.gov/pubmed/36870577
http://dx.doi.org/10.1016/j.ejps.2023.106418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9979628/
https://www.ncbi.nlm.nih.gov/pubmed/36870577
http://dx.doi.org/10.1016/j.ejps.2023.106418

Ejemplares similares